Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has earned a consensus recommendation of “Hold” from the five ...

Myelodysplastic syndrome (MDS) is a conglomerate of hematologic diseases characterized by dysplasia of hematopoietic stem cells and ineffective hematopoiesis in the bone marrow, causing variable ...

×20 and b. ×40). International System for Human Cytogenomic Nomenclature. The diagnosis of myelodysplastic syndrome (MDS) with multilineage dysplasia was established, according to the World Health ...

A research study co-authored by Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders will be ...

Darwen Football Club is to pay tribute to a woman, who died in January after being after being diagnosed with leukaemia.

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Systemic and topical ophthalmic steroids were initiated, with effective but incomplete reduction in intraocular inflammation. Cytogenetic analysis of bone marrow aspirate demonstrated myelodysplastic ...

Anemia remains a major public health concern in India, affecting women, children and pregnant mothers, leading to severe ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

Orca Bio has shared promising results from a late-stage study of its investigational allogeneic T-cell immunotherapy in ...

Research analysts at StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a ...